Fujikura Ltd and Micro-Imaging Solutions Enter into License Agreement for CMOS-based Imaging TechnologyMay 31, 2013 1:00 pm | by Business Wire | News | Comments
Fujikura Ltd and Micro-Imaging Solutions (MIS) announced that they have entered into a license agreement to jointly co-market nano-sized, complementary metal-oxide semiconductor, or CMOS, based endoscopes. The collaboration leverages the large, commercial scale production capabilities of Fujikura and the proprietary imaging technology of MIS.
Two independent teams have developed new optics-based methods for determining the exact viral load of a sample by counting individual virus particles. These new methods are faster and cheaper than standard tests and they offer the potential to conduct the measurements in a medical office or hospital instead of a laboratory.
A high-dose of ultrasound targeted to painful bone metastases appears to quickly bring patients relief, and with largely tolerable side effects, according to new research presented by Fox Chase Cancer Center scientists at the 49th Annual Meeting of the American Society of Clinical Oncology on Monday, June 3.
Scientists at Columbia University's Mailman School of Public Health and the Johns Hopkins University School of Medicine say their findings suggest a synergistic effect between lead exposure and a genetic risk factor, and open an avenue to better understanding the complex gene-environment interactions that put people at risk for schizophrenia and other mental disorders.
The medical device ecosystem is changing dramatically from stand-alone “device + patient + physician” in the clinical environment to include access and mobility outside the four walls of the hospital. This inforgraphic looks at how connected health can make an impact on the cost of healthcare.
The Endurant AAA stent graft system from Medtronic, Inc. continues to distinguish itself, with new data on the market-leading device for the endovascular repair of abdominal aortic aneurysms demonstrating durable clinical performance through three years of patient follow-up.
GE Healthcare Announces Commercial Availability of New Methodology That Provides a Cancer Profile on a Single SlideMay 31, 2013 9:00 am | by Business Wire | News | Comments
GE Healthcare today announced at the 2013 Annual Meeting of the American Society of Clinical Oncology its plans for the commercialization of MultiOmyx ™, a ground-breaking new pathology platform, using proprietary methodology to analyze multiple proteins at a single-cell level.
NuVasive, Inc., a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, is excited to announce the global launch of its Maximum Access Surgery Posterior Lumbar Interbody Fusion (MAS® PLIF) procedure.
New Method to Test Breast Lesions Could Better Detect Cancer, Save Money by Reducing Repeat BiopsiesMay 31, 2013 12:05 am | by AACR | News | Comments
A newly developed, single-step Raman spectroscopy algorithm has the potential to simultaneously detect microcalcifications and enable diagnosis of the associated breast lesions with high precision, according to data published in Cancer Research, a journal of the American Association for Cancer Research.
Applied Market Information, LLC (AMI) reveals the program for the Medical Grade Polymers 2013, the seventh in this series of high-level business conferences that takes place on September 17-18, 2013 at the Crowne Plaza Boston/Woburn in Woburn, MA.
WESTEC, the premier West Coast manufacturing event, will return to the Los Angeles Convention Center – October 15-17, 2013. Produced by the Society of Manufacturing Engineers (SME), WESTEC was previously scheduled as a spring 2014 event, but increased industry demand and participant feedback convinced the organizers to shift the date forward.
Research at Lund University in Sweden gives hope that one of the most serious types of brain tumor, glioblastoma multiforme, could be fought by the patients' own immune system. The tumors are difficult to remove with surgery because the tumor cells grow into the surrounding healthy brain tissue. A patient with the disease therefore does not usually survive much longer than a year after the discovery of the tumor.
Stent angioplasty saves lives, but there often are side effects and complications related to the procedure, such as arterial restenosis and thrombosis. In the June 2013 issue of The FASEB Journal, however, scientists report that they have discovered a new nanoparticle gene delivery method that may overcome current limitations of gene therapy vectors and prevent complications associated with the stenting procedure.
Procedures like angioplasty, stenting and bypass surgery may save lives, but they also cause excessive inflammation and scarring, which ultimately can lead to permanent disability and even death. A new research report appearing in The FASEB Journal, shows that naturally derived compounds from polyunsaturated fatty acids (omega-3s) may reduce the inflammation associated with these procedures to help arteries more fully and completely heal.
A new study from Columbia University School of Nursing supports a growing body of evidence that women are less likely to contract bloodstream or surgical site infections than their male counterparts. Researchers investigated the incidence of infection in thousands of hospitalized patients and found the odds for women succumbing to a bloodstream infection (BSI) and surgical-site infection (SSI) were significantly lower than for men.